Site icon pharmaceutical daily

Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2021-2026” report has been added to ResearchAndMarkets.com’s offering.

Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years.

The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.

The report presents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.

Key Questions Answered in this Report:

 

Key Topics Covered:

 

1 Preface

 

2 Scope and Methodology

 

3 Executive Summary

 

4 Brazil Generic Drug Market – Introduction

4.1 What are Generic Drugs?

4.2 Classification of Generic Drugs

 

5 Why is the Brazil Generic Drug Market So Lucrative

5.1 Drug Patent Expiries

5.2 Lower Costs

5.3 Government Support

5.4 Increasing Consumer Confidence

5.5 Increasing Access to Generic Drugs

5.6 High Growth Potential for Biosimilar Drugs

 

6 Global Generic Drug Market

6.1 Generic Drug Market Performance

6.1.1 Value Trends

6.1.2 Volume Trends

6.2 Market Breakup by Country

6.3 Most Prescribed Generic and Branded Drugs

6.4 Market Forecast

 

7 Brazil Generic Drug Market

7.1 Brazil Pharmaceutical Market Performance

7.1.1 Value Trends

7.1.2 Volume Trends

7.1.3 Market Breakup by Type

7.1.4 Market Forecast

7.2 Brazil Generic Drug Market Performance

7.2.1 Value Trends

7.2.2 Volume Trends

7.2.3 Impact of COVID-19

7.2.4 Market Forecast

 

8 Brazil Generic Drug Industry: SWOT Analysis

8.1 Overview

8.2 Strengths

8.3 Weaknesses

8.4 Opportunities

8.5 Threats

 

9 Brazil Generic Drug Industry: Value Chain Analysis

9.1 Research and Development

9.2 Manufacturing

9.3 Marketing

9.4 Distribution

9.5 Pricing

 

10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain

 

11 Brazil Generic Drug Industry: Porter’s Five Forces Analysis

 

12 Brazil Generic Drug Market: Competitive Landscape

12.1 Brazil Generic Drug Market: Competitive Structure

12.2 Brazil Generic Drug Market: Market Share of Key Players

12.3 Distribution Channels

 

13 Government Policy

 

14 Brazil Generic Drug Market: Key Success Factors

 

15 Brazil Generic Drug Market: Road Blocks

 

16 Generic Drug Manufacturing Process

16.1 Manufacturing Process

16.2 Raw Material Requirements

16.3 Raw Materials Pictures

16.4 Land and Construction Requirements

16.5 Machinery and Infrastructure Requirements

16.6 Machinery Pictures

16.7 Plant Layout

16.8 Packaging Requirements

16.9 Utility Requirements

16.10 Manpower Requirements

 

17 Brazil Generic Drug Market: Key Company Profiles

 

For more information about this report visit https://www.researchandmarkets.com/r/rnzml3.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version